Alpha Tau Medical raises $29m

Alpha Tau Medical said today it raised $29 million in a private funding round to help support its alpha radiation cancer therapy technology. The round was led by Israeli private equity firm Shavit Capital and joined by global equity crowdfunding platform OurCrowd.com and Medison Pharma venture capital arm Medison Ventures, the Israel-based company said. The round was also joined by Apax Partner founds Ronald Cohen and Alan Patricof, Alpha Tau said. “We are confident that Alpha Tau’s ground-breaking technology can be a game changer in the treatment of cancer. Importantly, under the guidance of an experienced management team, the company has already achieved strategic relationships and trials with leading international medical research centers and is positioned to become a world leader in the development of next-generation radiation oncology therapies,” Shavit Capital founder & managing partner Gary Leibler said in a prepared release. “We are delighted at Alpha Tau’s rapid development of this important treatment, and are very optimistic about the Alpha DaRT’s potential to activate the immune system and to become a valid treatment option for metastatic cancer,” Medison Pharma founder & CEO Meir Jakobsohn said in a press release. The company is developing an alpha-radiation-based cancer treatment, dubbed the Alpha DaRT, for treating different types of solid tumors. The system is intended to deliver high-precision alpha-rad...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Funding Roundup Alpha Tau Medical Source Type: news